Correlation Between Olema Pharmaceuticals and Bioatla

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Olema Pharmaceuticals and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Olema Pharmaceuticals and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Olema Pharmaceuticals and Bioatla, you can compare the effects of market volatilities on Olema Pharmaceuticals and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Olema Pharmaceuticals with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Olema Pharmaceuticals and Bioatla.

Diversification Opportunities for Olema Pharmaceuticals and Bioatla

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Olema and Bioatla is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Olema Pharmaceuticals and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Olema Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Olema Pharmaceuticals are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Olema Pharmaceuticals i.e., Olema Pharmaceuticals and Bioatla go up and down completely randomly.

Pair Corralation between Olema Pharmaceuticals and Bioatla

Given the investment horizon of 90 days Olema Pharmaceuticals is expected to under-perform the Bioatla. But the stock apears to be less risky and, when comparing its historical volatility, Olema Pharmaceuticals is 1.39 times less risky than Bioatla. The stock trades about -0.29 of its potential returns per unit of risk. The Bioatla is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest  49.00  in Bioatla on November 28, 2024 and sell it today you would lose (11.00) from holding Bioatla or give up 22.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Olema Pharmaceuticals  vs.  Bioatla

 Performance 
       Timeline  
Olema Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Olema Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Bioatla 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Olema Pharmaceuticals and Bioatla Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Olema Pharmaceuticals and Bioatla

The main advantage of trading using opposite Olema Pharmaceuticals and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Olema Pharmaceuticals position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.
The idea behind Olema Pharmaceuticals and Bioatla pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes